Furthermore, we identified nuclear Eg5 as a prognostic marker in hormone-naive PCa patients: patients whose tumor expressed nuclear Eg5 had a decreased median OS and progressed more rapidly to mCRPC. This evidence concerns the gene KIF11 and neoplasm.